Radiolabeled Glass Beads in Treating Patients With Liver Cancer That Cannot be Removed by Surgery
Status:
Completed
Trial end date:
2021-06-15
Target enrollment:
Participant gender:
Summary
This clinical trial studies radiolabeled glass beads (yttrium Y 90 glass microspheres) in
treating patients with unresectable hepatocellular carcinoma. Internal radiation therapy uses
radioactive material placed directly into or near a tumor to kill tumor cells. Using
radiolabeled glass beads to kill tumor cells may be an effective treatment for liver cancer.